Israel Rubinstein
Critical Care Medicine · Chicago, ILNPI 1942305966
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $87,046 of the $107,088 with a category attached, or 81.3%. Mylan Specialty L.p. accounts for 76.6% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $74,940 and has fallen 87.4% since, to $9,433 in 2025. Among critical care medicine clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 184 payments — averaging $582.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mylan Specialty L.p.$82K
- GSK$9K
- Sunovion Pharmaceuticals Inc.$5K
- Insmed, Inc.$5K
- AstraZeneca$4K
- GE HealthCare$2K
- plus $729 from 4 others
What the payments were for
- Consulting fees$8,4128%
- Speaking & faculty fees$87,04681%
- Travel & lodging$9,6339%
- Food & beverage$1,9332%
- Education$490%
- Gifts$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mylan Specialty L.p. | 143 | $82,035 |
| GSK | 20 | $9,433 |
| Sunovion Pharmaceuticals Inc. | 4 | $5,063 |
| Insmed, Inc. | 6 | $4,587 |
| AstraZeneca | 6 | $3,555 |
| GE HealthCare | 1 | $1,686 |
| Advanced Respiratory, Inc | 1 | $360 |
| Resmed Corp | 1 | $250 |
| Merck | 1 | $107 |
| Circassia Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Yupelri$80,427
- NUCALA$8,450
- LONHALA MAGNAIR$4,950
- Arikayce$4,400
- SYMBICORT$3,469
- Life 2000 Ventilation System$360
- AIR 11$250
How this compares
$107,088 in reported general payments places this provider in the 95th percentile of 281 critical care medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $388 |
Paid to pharmacies, not to this prescriber.
Other critical care medicine in Chicago
- Michael CutticaChicago$402K
- Abbas Al-QamariChicago$40K
- Michael RiesChicago$13K
- Marc SalaChicago$8K
- Marie StockChicago$7K
- Brian HarrChicago$7K
- Dean SchraufnagelChicago$6K
- Kristin ShannonChicago$5K
- Mohamed AfifiChicago$4K
- Clifton ClarkeChicago$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.